| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/25/2004 | EP1391450A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 02/25/2004 | EP1390363A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 02/25/2004 | EP1390356A1 Arylisoxazoline derivatives, method for production and use thereof as pesticides |
| 02/25/2004 | EP1390350A1 Novel compounds |
| 02/25/2004 | EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 02/25/2004 | EP1390029A1 Phenylindoles for the treatment of hiv |
| 02/25/2004 | EP1283837B1 New thiochromane derivatives and their use as thrombin inhibitors |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | EP1219610B1 Process for the preparation of oxazole derivatives |
| 02/25/2004 | EP1211246B1 Pyrimidine derivatives and herbicides containing the same |
| 02/25/2004 | EP1206469B1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 02/25/2004 | EP1042296B1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 02/25/2004 | EP1040108B1 Ortho-anthranilamide derivatives as anti-coagulants |
| 02/25/2004 | CN1478092A Benzoxazinone derivatives, their preparation and use |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1139580C Substituted benzylamines and their use for treatment of depression |
| 02/25/2004 | CN1139578C Preparation of isoxazoline-3-yl-acyl benzene |
| 02/25/2004 | CN1139577C Improved process for preparation of unsymmetrical 4,6-bis(aryloxy) pyrimidine compounds |
| 02/24/2004 | US6696474 Such as 8-(5-methyl-2-phenyl-oxazol-4-yl)-2-pyrrol-1-yl-oct-4-ynoic acid; noninsulin dependent diabetes mellitus |
| 02/24/2004 | US6696459 Using high affinity, high selectivity quinoline derivativesw |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents |
| 02/24/2004 | CA2150944C New taxoids; process for preparing the same and pharmaceutical compositions containing them |
| 02/19/2004 | WO2004014902A2 Compounds having an activity at metabotropic glutamate receptors |
| 02/19/2004 | WO2004014901A1 Process for preparing zolmitriptan compounds |
| 02/19/2004 | WO2004014900A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 02/19/2004 | WO2004014897A1 N-aryl-2-oxazolidinones and their derivatives |
| 02/19/2004 | WO2004014892A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014881A2 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 02/19/2004 | WO2004014879A1 New process |
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | WO2004014868A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014864A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors |
| 02/19/2004 | WO2004014860A2 Fused heterocyclic compounds as peptidase inhibitors |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014392A1 Oxazolidinone derivatives as antimicrobials |
| 02/19/2004 | WO2004014389A1 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014384A2 Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014379A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014377A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014370A2 Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 02/19/2004 | WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | WO2004014366A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 02/19/2004 | WO2004006886A3 Injectable depot formulation comprising crystals of iloperidone |
| 02/19/2004 | WO2003027234A9 Small organic molecule regulators of cell proliferation |
| 02/19/2004 | US20040034239 Inhibitors of nadh:ubiquinone oxidoreductase |
| 02/19/2004 | US20040034222 Phenyloxyalkylamino substituted triazine compound, useful for applying to the parts of the plants, to plant seed or to the area under cultivation as plant growth regulator |
| 02/19/2004 | US20040034218 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 02/19/2004 | US20040034089 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins |
| 02/19/2004 | US20040034084 Side effect reduction; for treatment of AIDS, cancer and arthritis |
| 02/19/2004 | US20040034081 Estrogen receptor modulators |
| 02/19/2004 | US20040034078 Such as 2-(2-butylamino-ethylsulfanylmethyl)-1H-benzimidazole-4-carboxylic acid amide for treatment of cancer, strokes, head trauma, and neurodengenerative diseases; solid phase synthesis |
| 02/19/2004 | US20040034073 Analgesic agents, modulating the activity of a cannabinoid receptor, treating hypertension, inflammation, pain, autoimmune diseases, allergic diseases, glaucoma, multiple sclerosis, Huntington's chorea, spinal chord injury |
| 02/19/2004 | US20040034064 2-(biarylalkyl)amino-3-(alkanoylamino)pyridine derivatives |
| 02/19/2004 | US20040034063 Antiallergens for treating and prevention of asthma |
| 02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/19/2004 | US20040034037 Heteroaryl compounds useful as inhibitors of GSK-3 |
| 02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/19/2004 | US20040033994 Use of compounds comprising a nitrogen-oxygen heterocycle |
| 02/19/2004 | US20040033969 Such as penicillin G coupled to 2'deoxyazithromycin; drug delivery |
| 02/19/2004 | US20040033899 5[(pyrazol-4-yl)carbonyl]benzazolone as herbicide |
| 02/19/2004 | DE10236340A1 New heteroar(alkan)oyl-substituted phenyl-beta-alaninamide derivatives, useful as broad-spectrum antibacterial agents in human or veterinary medicine |
| 02/19/2004 | DE10235690A1 New N-benzyl-anthranilic acid (hetero)arylamide derivatives and analogs, are tyrosine kinase KDR and FLT inhibitors and angiogenesis inhibitors, useful e.g. for treating tumors, psoriasis or restenosis |
| 02/19/2004 | CA2497656A1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2495179A1 Compounds having an activity at metabotropic glutamate receptors |
| 02/19/2004 | CA2495120A1 Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 02/19/2004 | CA2495067A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | CA2494298A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | CA2494048A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2494014A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | CA2492019A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2491287A1 N-aryl-2-oxazolidinones and their derivatives |
| 02/18/2004 | EP1389617A1 Heterocyclic compound and antitumor agent containing the same as active ingredient |
| 02/18/2004 | EP1389616A1 Novel benzylpiperidine compound |
| 02/18/2004 | EP1389205A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 02/18/2004 | EP1389202A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 02/18/2004 | EP1389191A1 Heterocyclyl phenyl benzyl ethers used as fungicides |
| 02/18/2004 | EP1389190A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 02/18/2004 | EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 02/18/2004 | EP1196410B1 Respiratory syncytial virus replication inhibitors |
| 02/18/2004 | EP1183252B1 pharmaceutically active compounds |
| 02/18/2004 | EP1119568B1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 02/18/2004 | EP0944627B1 8-azabicyclo 3.2.1]octane-, 8-azabicyclo 3.2.1]oct-6-ene-, 9-azabicyclo 3.3.1]nonane-, 9-aza-3-oxabicyclo 3.3.1]nonane- and 9-aza-3-thiabicyclo 3.3.1]nonane derivatives, their preparation and their use as insecticides |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity |
| 02/18/2004 | CN1476436A Novel compounds for use as HIV protease inhibitors |
| 02/18/2004 | CN1476432A Indole and dihydroindole derivatives |
| 02/18/2004 | CN1138773C 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
| 02/18/2004 | CN1138765C Oxazolidinone antibacterial agents having thiocarbonyl functionality |
| 02/18/2004 | CN1138764C Isoxazole derivatives |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |